Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| Rosen AD | 2003 | intact cell/cell culture, GH3 cells (a murine pituitary cell line) | static magnetic field, DC | 125 mT |
| Sonnier H et al. | 2003 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, static magnetic field, 50/60 Hz | 0.072–7.5 mT |
| Obo M et al. | 2002 | intact cell/cell culture, PC-12D cells (subline of the PC-12 cell line, derived from pheochromocytoma cells from the rat adrenal medulla) | magnetic field, static magnetic field, 50/60 Hz | 14.8–150 µT |
| Lindstrom E et al. | 2001 | intact cell/cell culture, Jurkat cells (clone E6-1; T-lymphocyte hybridoma cell line) | magnetic field, static magnetic field, 50/60 Hz, DC | 10 µT–0.1 mT |
| Satow Y et al. | 2001 | isolated organ, sartorius muscles of bullfrogs (<i>Rana catesbeiana</i>) | static magnetic field | 0.65 T |
| Sonnier H et al. | 2000 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, static magnetic field, 50/60 Hz | 80 µT–7.5 mT |
| Griffin GD et al. | 2000 | intact cell/cell culture, Clone 9 cells (normal rat liver cell line) | magnetic field, low frequency, DC, static magnetic field, co-exposure | 23.8–36.6 µT |
| Pacini S et al. | 1999 | intact cell/cell culture, FNC-B4 (human neuronal cells), MCF-7 (human breast carcinoma cells) and WEHI-3 (murine leukemia cells) | static magnetic field, MRI | 200 mT |
| Takeshige C et al. | 1996 | animal, guinea pig, partial body: leg (gastrocnemius muscle) | static magnetic field, electrotherapy, co-exposure, therapeutic/medical device | 130 mT |
| Trabulsi R et al. | 1996 | tissue slices, (derived of mouse hippocampus) | static magnetic field, DC | 10 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
